Lindynette

Ethinylestradiol / Gestodene, the active ingredient in Lindynette, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus, while also providing cycle control and reduced risk of unintended pregnancy when taken as directed.

GNH USA supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lindynette, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual disorders.

Prevention of pregnancy: provides reliable contraception for women of childbearing potential. Management of dysmenorrhea: reduces menstrual pain associated with ovulation. Treatment of acne: improves hormonal acne in women by regulating androgen levels.

Like all hormonal contraceptives, Lindynette may be associated with a range of adverse reactions.

Common Side Effects: - Nausea or mild gastrointestinal discomfort. - Breast tenderness or enlargement. - Headache or migraine onset. - Spotting or breakthrough bleeding between periods. - Weight fluctuation or fluid retention. - Mood changes or mild depression.

Serious or Rare Side Effects: - Venous thromboembolism, including deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis such as stroke or myocardial infarction. - Severe hypertension or hypertensive crisis. - Liver dysfunction, including cholestatic jaundice. - Anaphylactic or severe allergic reactions.

Before prescribing Lindynette, clinicians should evaluate individual risk factors and ensure appropriate patient counseling.

Assess cardiovascular risk: evaluate history of thromboembolic events before prescribing. Screen for liver disease: avoid use in active hepatic dysfunction. Consider smoking status: contraindicated in women over 35 who smoke. Review medication history: identify potential drug interactions that may reduce efficacy. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lindynette can interact with several medicines that affect hormone metabolism or efficacy.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) may markedly reduce contraceptive effectiveness. - Rifampicin or other strong CYP3A4 inducers can lead to breakthrough bleeding. - St. John's wort may decrease plasma hormone levels, compromising contraception.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline or metronidazole may slightly lower efficacy; advise backup contraception. - Antifungal agents (e.g., ketoconazole, itraconazole) can increase hormone concentrations, raising risk of side effects. - Diuretics may affect fluid balance and blood pressure; monitor patient response.